April 01, 2024 Carisma Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
March 28, 2024 Vicore Announces Presentations at the 2024 American Thoracic Society International Conference
March 27, 2024 Oncopeptides and Vector Pharma FZCO Announce Collaboration to Provide Pepaxti to Patients in the Middle East and North Africa
March 26, 2024 Aprea Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Business Update
March 19, 2024 HealthCap portfolio company Fusion Pharmaceuticals to be acquired by AstraZeneca for up to USD 2.4 billion
March 19, 2024 Fusion Pharmaceuticals To Be Acquired By AstraZeneca, Accelerating Development Of Next-Generation Radioconjugates To Treat Cancer
March 19, 2024 Vicore Announces FDA Breakthrough Device Designation for AlmeeTM, a Digital Therapy for Patients with Pulmonary Fibrosis